Dairy farmers' considerations for antimicrobial treatment of clinical mastitis in British Columbia and Alberta, Canada.
| Autor: | de Jong E; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada., van der Velden I; Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands., Smid AC; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada., Ida JA; Department of Population Medicine and Diagnostic Sciences, Cornell University, Ithaca, NY, United States., Reyher KK; University of Bristol Veterinary School, Bristol, United Kingdom., Kelton DF; Department of Population Medicine, Ontario Veterinary College, University of Guelph, Guelph, ON, Canada., Barkema HW; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Frontiers in veterinary science [Front Vet Sci] 2024 Aug 08; Vol. 11, pp. 1417958. Date of Electronic Publication: 2024 Aug 08 (Print Publication: 2024). |
| DOI: | 10.3389/fvets.2024.1417958 |
| Abstrakt: | Introduction: Clinical mastitis (CM) treatment decision-making is a multifaceted process that remains relatively understudied, despite CM being one of the most prevalent diseases on dairy farms worldwide, contributing greatly to the use of antimicrobials in the dairy industry. This study aimed to gain insights into decision-making mechanisms employed by dairy farmers in British Columbia and Alberta, Canada, when dealing with CM. Methods: Interviews were held with 15 dairy farmers in the Canadian provinces of British Columbia and Alberta and analyzed using reflexive thematic analysis to develop both the decision-pathway and overarching themes influencing the CM decisions by farmers in this region. Results and Discussion: The analysis generated a decision-making process that begins with identification and classification of CM, guided by visual characteristics of milk and the udder, available milk production and quality data, presence of systemic signs, and additional diagnostics. Subsequently, CM cases are assessed based on the likelihood of cure, value of the cow, and herd goals to decide whether antimicrobial treatment is desired. Next, a treatment choice is made by evaluating severity and urgency of the case, availability of drugs and timing of the case. Finally, definition of treatment success and progression over time following the treatment decision guides the termination of treatment. Three overarching themes were generated that shape the decision-making process: 'Personal attributes', including personal approach and experiential knowledge; 'Inter-actor dynamics', such as shared decision-making and dynamics among producers, veterinarians, and milkers; and 'Moving beyond protocols', which highlights the dynamic nature of mastitis decision-making. These insights have the potential to inform the development of effective interventions to improve CM antimicrobial use that align with the reality of farming operations within Western Canada, and potentially beyond. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2024 de Jong, van der Velden, Smid, Ida, Reyher, Kelton and Barkema.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|